Home Cart Sign in  
Chemical Structure| 103628-46-2 Chemical Structure| 103628-46-2

Structure of Sumatriptan
CAS No.: 103628-46-2

Chemical Structure| 103628-46-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sumatriptan is an orally active 5-HT1 receptor agonist with IC50 values of 7.3 nM, 9.3 nM, and 17.8 nM for 5-HT1D, 5-HT1B, and 5-HT1F receptors, respectively. It is used for migraine research.

Synonyms: GR 43175 free base

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sumatriptan

CAS No. :103628-46-2
Formula : C14H21N3O2S
M.W : 295.40
SMILES Code : O=S(CC1=CC2=C(NC=C2CCN(C)C)C=C1)(NC)=O
Synonyms :
GR 43175 free base
MDL No. :MFCD00866222

Safety of Sumatriptan

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H361-H412
Precautionary Statements:P201-P202-P273-P280-P308+P313-P405-P501

Related Pathways of Sumatriptan

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06503848 Migraine Disorders RECRUITING 2025-12-24 Hospital Universitari Vall d'H... More >>ebron, Barcelona, Spain Less <<
NCT02932488 Healthy Volunteers PHASE1 TERMINATED 2025-06-19 Neurobiology Research Unit, Ri... More >>gshospitalet, Copenhagen, 2100, Denmark Less <<
NCT01269281 Healthy PHASE1 COMPLETED 2025-07-05 BA Research India Limited, Bod... More >>akdev, Ahmedabad, 380 054, India Less <<
NCT01507610 Migraine PHASE1 COMPLETED 2025-02-12 Celerion, Neptune, New Jersey,... More >> 07753, United States Less <<
NCT01376141 Migraine Disorders COMPLETED 2025-11-05 -
NCT00620425 Healthy PHASE1 COMPLETED 2025-12-07 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.39mL

0.68mL

0.34mL

16.93mL

3.39mL

1.69mL

33.85mL

6.77mL

3.39mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories